Torrent Pharmaceuticals
BSE 500420
7 stories, newest first.
- Torrent Pharma uploads audio recording of Q2/H1 FY27 results analyst conference call
- Consolidated results for the quarter ended 30-Sep-2026 Unaudited
- Executive Director Amal Kelshikar tenders resignation, effective 16th October 2026
- Torrent Pharmaceuticals to hold post Q2/H1 FY27 results conference call with investors and analysts on 23 October 2026
- India Ratings affirms IND AA+ and revises outlook to positive from stable; CP at IND A1+
- Board meeting on 23-Oct-26 to consider and approve results for the quarter and half year ended 30-Sep-26
- Torrent Pharma raises Torrent Urja 27 investment to INR 11.88 crore for 26% stake
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.